Abstract
Superficial CD34-positive fibroblastic tumor (SCPFT) is an extremely rare neoplasm with an indolent behavior. It was incorporated for the first time in the fifth edition of the World Health Organization (WHO) classification in the rarely metastasizing category of soft tissue tumors with an intermediate biological potential. It is a challenging clinical entity coupled with a pathological dilemma due to moderate to marked pleomorphism in tumor cells mimicking various sarcomas. Histologically, these tumors appear to be malignant at the outset but atypical mitosis or necrosis are rarely seen. These cells show diffuse positivity for CD34 and are focally positive for Pan-cytokeratin which further aids in diagnosis. Some of the SCPFT harbor PRDM10 rearrangement; however, the diagnosis does not require molecular testing. We are discussing a series of five cases of SCPFT, highlighting the diagnostic histological and immune-histochemical features of this enigmatic entity. We pen down the series as an accurate histopathological diagnosis of SCPFT is undoubtedly a key to prevent its misdiagnosis as a malignant tumor with drastically different clinical implications.
This is a preview of subscription content, log in via an institution to check access.
Data Availability
All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.
References
(2020) WHO Classification Soft Tissue and Bone Tumours . 5th ed. IARC
Carter JM, Weiss SW, Linos K, DiCaudo DJ, Folpe AL (2014) Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 27(2):294–302. https://doi.org/10.1038/modpathol.2013.139
Sood N, Khandelia BK (2017) Superficial CD34-positive fibroblastic tumor: a new entity; case report and review of literature. Indian J Pathol Microbiol 60(3):377–380. https://doi.org/10.4103/IJPM.IJPM_589_16
Hendry SA, Wong DD, Papadimitriou J, Robbins P, Wood BA (2015) Superficial CD34-positive fibroblastic tumour: report of two new cases. Pathology 47(5):479–482. https://doi.org/10.1097/PAT.0000000000000281
Lao IW, Yu L, Wang J (2017) Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 70(3):394–401. https://doi.org/10.1111/his.13088
Wada N, Ito T, Uchi H, Nakahara T, Tsuji G, Yamada Y, Oda Y, Furue M (2016) Superficial CD34-positive fibroblastic tumor: a new case from Japan. J Dermatol 43(8):934–936. https://doi.org/10.1111/1346-8138.13327
Anderson WJ, Mertens F, Mariño-Enríquez A, Hornick JL, Fletcher CD (2022) Superficial CD34-positive fibroblastic tumor: a clinicopathologic, immunohistochemical, and molecular study of 59 cases. Am J Surg Pathol 46(10):1329–1339
Perret R, Michal M, Carr RA, Velasco V, Švajdler M, Karanian M, Meurgey A, Paindavoine S, Soubeyran I, Coindre JM, Boidot R (2021) Superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor are overlap** entities: a comprehensive study of 20 cases. Histopathology 79(5):810–825
Zambo I, Veselý K (2014) WHO klasifikace nádorů měkkých tkání a kostí 2013: hlavní změny oproti 3. vydání [WHO classification of tumours of soft tissue and bone 2013: the main changes compared to the 3rd edition]. Cesk Patol 50(2):64–70. Czech
Gru AA, Santa Cruz DJ (2013) Atypical fibroxanthoma: a selective review. Semin Diagn Pathol 30(1):4–12. https://doi.org/10.1053/j.semdp.2012.01.001
Miller K, Goodlad JR, Brenn T (2012) Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma. Am J Surg Pathol 36(9):1317–1326. https://doi.org/10.1097/PAS.0b013e31825359e1
Hofvander J, Puls F, Pillay N, Steele CD, Flanagan AM, Magnusson L, Nilsson J, Mertens F (2019) Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile. J Pathol 249(4):425–434. https://doi.org/10.1002/path.5326
Hofvander J, Tayebwa J, Nilsson J, Magnusson L, Brosjö O, Larsson O, Vult von Steyern F, Mandahl N, Fletcher CD, Mertens F (2015) Recurrent PRDM10 gene fusions in undifferentiated pleomorphic sarcoma. Clin Cancer Res 21(4):864–9. https://doi.org/10.1158/1078-0432.CCR-14-2399
Wood L, Fountaine TJ, Rosamilia L, Helm KF, Clarke LE (2010) Cutaneous CD34+ spindle cell neoplasms: histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans. Am J Dermatopathol 32(8):764–768. https://doi.org/10.1097/DAD.0b013e3181d0c587
Neagu TP, Sinescu RD, Enache V, Achim SC, Ţigliş M, Mirea LE (2017) Metastatic high-grade myxofibrosarcoma: review of a clinical case. Rom J Morphol Embryol 58(2):603–609
Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH (2012) Recurrence patterns and survival for patients with intermediate- and high-grade myxofibrosarcoma. Int J Radiat Oncol Biol Phys 82(1):361–367. https://doi.org/10.1016/j.ijrobp.2010.08.042
Bahrami A, Folpe AL (2010) Adult-type fibrosarcoma: a reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol 34(10):1504–1513. https://doi.org/10.1097/PAS.0b013e3181ef70b6
Yamaga K, Fujita A, Osaki M, Kuwamoto S, Ishiguro N, Yamamoto T, Nagashima H (2017) Detailed analysis of a superficial CD34-positive fibroblastic tumor: a case report and review of the literature. Oncol Lett 14(3):3395–3400. https://doi.org/10.3892/ol.2017.6636
Hamada T, Katsuki N, Hosokawa Y, Ayano Y, Ikeda M (2019) Additional case of superficial CD34-positive fibroblastic tumor in a Japanese patient. J Dermatol 46(4):e134–e136. https://doi.org/10.1111/1346-8138.14629
Batur S, Ozcan K, Ozcan G, Tosun I, Comunoglu N (2019) Superficial CD34 positive fibroblastic tumor: report of three cases and review of the literature. Int J Dermatol 58(4):416–422. https://doi.org/10.1111/ijd.14357
Lin TL, Yang CS, Juan CK, Weng YC, Chen YJ (2020) Superficial CD34-positive fibroblastic tumor: a case report and review of the literature. Am J Dermatopathol 42(1):68–71. https://doi.org/10.1097/DAD.0000000000001355
Mao X, Sun YY, Deng ML, Ma T, Yu L (2020) Superficial CD34-positive fibroblastic tumor: report of two cases and review of literature. Int J Clin Exp Pathol 13(1):38–43
Bruce-Brand C, Conradie W, Schneider JW (2023) Superficial CD34 positive fibroblastic tumour with myxoid stroma. Int J Surg Pathol 31(5):751–754. https://doi.org/10.1177/10668969221126109
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Consent to participate
The authors certify that they have obtained all appropriate patient consent forms.
Consent for publication
Informed consent was sought from the patient regarding participation and publication.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Das, S., Khan, A.A., Jacob, S. et al. Diagnostic conundrum of Superficial CD34-positive fibroblastic tumor (SCPFT): a series of five cases. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-02022-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13193-024-02022-9